Cempra Holdings (CEMP) Files $86.5M IPO
Tweet
Share
E-mailGet Alerts CEMP Hot Sheet
Join SI Premium – FREE
Cempra Holdings, LLC (Nasdaq: CEMP) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. Te proposed maximum offering price is $86.5 million. Cempra plans to list on the Nasdaq Global Market under the ticker "CEMP."
The offering is being made through Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company, and Needham & Company, LLC.
Cempra is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and skin and skin structure infections.
The offering is being made through Stifel Nicolaus Weisel, Leerink Swann, Cowen and Company, and Needham & Company, LLC.
Cempra is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and skin and skin structure infections.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ITG prices IPO at $16 per share on Nasdaq
- Vishay Intertechnology launches $750M common stock offering
- QXO closes TopBuild acquisition, targets $300M in annual synergies
Create E-mail Alert Related Categories
IPOsRelated Entities
Stifel, Needham & Company, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
